New HNB Device to be Launched by Japan Tobacco

Sep.24.2024
New HNB Device to be Launched by Japan Tobacco
According to N. News on September 24th, Japan Tobacco International Korea will launch an HNB device in late October.

According to a report by N. News on September 24, industry sources have revealed that Japan Tobacco International's South Korea branch will launch a HNB device (HTP) at the end of October this year.


A spokesperson for the company stated,


We plan to launch HNB devices (HTP) in the second half of the year. However, since it has not been officially released yet, details such as the brand name and specifications cannot be disclosed at this time.


JT International (JTI) is currently selling its heated tobacco products "Ploom Tech with2" and HTP device "Ploom X" in Japan. JTI previously launched "Ploom Tech" in South Korea in 2019, entering the e-cigarette market, but withdrew from the market in 2021.


Data shows that the HTP market in South Korea is currently in a growth phase. According to the Ministry of Strategy and Finance, cigarette sales decreased by 2.8% in 2023, while HTP sales increased from around 540 million packs in 2022 to around 610 million packs in 2023, representing a growth rate of 12.6%.


Currently, the HTP market in South Korea is primarily dominated by KT&G's "Lil" and Philip Morris International (PMI)'s "IQOS". In addition, British American Tobacco (BAT) is breaking into the market with "Glo".


According to market research firm Euromonitor, the size of the HTP market in South Korea has increased from 359.7 billion Korean won (270 million USD) in 2017 to 2 trillion Korean won (1.5 billion USD) in 2021. It is predicted that this number will reach 2.5 trillion Korean won (1.87 billion USD) next year.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

New Zealand medical research: E-cigarettes have become a normalized tool among Māori youth, and scholars are calling for restrictions on device design
New Zealand medical research: E-cigarettes have become a normalized tool among Māori youth, and scholars are calling for restrictions on device design
Dr. Robin Quigg from the University of Otago in New Zealand conducted a study on e-cigarette use among young Māori people and found that more than half of the participants aged 18 to 26 had used e-cigarettes despite having no history of smoking. Due to the small size and discreet smell of e-cigarettes, combined with the addictive nature of nicotine, their use has become normalized in public places and the usage rate among young Māori people is on the rise. Dr. Quigg called for stricter regulatio
Aug.28 by 2FIRSTS.ai
Singapore Proposes Class C Listing for Nitazenes; Offenders Could Face Jail Time
Singapore Proposes Class C Listing for Nitazenes; Offenders Could Face Jail Time
Singapore’s Ministry of Health plans to classify nitazenes, a sedative found in one-third of tested e-cigarettes, as a Class C controlled substance under the Misuse of Drugs Act. The move follows reports of related fatalities. Once enforced, offenders could face mandatory rehabilitation and imprisonment, similar to penalties for hard drugs.
Jul.21 by 2FIRSTS.ai
UK Stoke-on-Trent Police Crack Down on Illegal Tobacco and Vapes, Seize Products Worth $920,000
UK Stoke-on-Trent Police Crack Down on Illegal Tobacco and Vapes, Seize Products Worth $920,000
Stoke-on-Trent authorities seized £700,000 ($920,000) in illegal tobacco and vapes from a storage unit, including 638,380 cigarettes, 108 kg of tobacco, and 1,262 vapes. The renter is under investigation. Officials warned of serious consequences for organized crime.
Aug.01 by 2FIRSTS.ai
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore to Classify Etomidate as Class C Drug from September; Importers and Sellers Face Up to 20 Years in Prison
Singapore will classify the anesthetic etomidate as a Class C drug from September 1, with traffickers and users facing prosecution and a minimum one-year jail term. The move comes amid growing concerns over the health risks posed by etomidate-laced e-cigarettes, which have become increasingly popular. The government has stepped up enforcement efforts, seizing over 850 e-cigarettes in recent operations.
Aug.25 by 2FIRSTS.ai
Legal Commentary: FDA Approves JUUL Menthol E-Cigarettes and Releases Key Scientific Evaluation Criteria
Legal Commentary: FDA Approves JUUL Menthol E-Cigarettes and Releases Key Scientific Evaluation Criteria
2Firsts received a legal commentary from lawyer Zheng Mingwei’s team, analyzing the FDA’s approval of JUUL menthol e-cigarettes. The article outlines key scientific data, regulatory standards, and industry implications.
Jul.22
Jakarta’s Smoke-Free Zone Legislation Faces Criticism – Public Health Advocate: “It Will Not Harm Small Businesses”
Jakarta’s Smoke-Free Zone Legislation Faces Criticism – Public Health Advocate: “It Will Not Harm Small Businesses”
Jakarta’s new regulation is expected to improve public health, while experts call for collective efforts to counter misinformation, stressing that smoke-free zone policies can balance both health and economic development.
Aug.20 by 2FIRSTS.ai